ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,432,000 | -24.0% | 31,690 | -37.1% | 0.40% | -43.4% |
| Q4 2019 | $3,198,000 | +18.8% | 50,411 | -47.2% | 0.70% | -1.3% |
| Q3 2019 | $2,691,000 | +39.8% | 95,508 | +31.5% | 0.71% | +51.2% |
| Q2 2019 | $1,925,000 | +30.1% | 72,636 | -9.9% | 0.47% | +29.8% |
| Q1 2019 | $1,480,000 | +37.4% | 80,643 | -7.0% | 0.36% | +24.3% |
| Q4 2018 | $1,077,000 | -77.3% | 86,696 | -65.0% | 0.29% | -58.6% |
| Q3 2018 | $4,746,000 | +312.3% | 247,549 | +192.5% | 0.70% | +289.5% |
| Q2 2018 | $1,151,000 | – | 84,633 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |